Model for projecting COVID-19 hospital and ICU admissions, complete with code RIVM has published the code for model projections of COVID-19 hospital and ICU admissions. The code has been shared as part of a manuscript about the model.
Last chance for young adults to get vaccinated against HPV for free Today sees the launch of the ‘Do not miss out’ campaign, which calls on young people to get the first dose of the vaccine against the human papillomavirus (HPV) as soon as possible.
Breast implants can cause health problems even five years or more after placement Over the past 5 years, the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI) has received 977 reports of health problems related to breast implants. An analysis by RIVM has shown that 39% of the reported health problems started 5 or more years after the implant’s placement.
No indication that investigated mesh implants used to treat pelvic organ prolapse are unsafe RIVM has conducted a laboratory study into six mesh implants from different manufacturers used in the Netherlands in 2018. The study revealed no indication that these products are unsafe for patients.
Exposure to combination of chemicals appears to be too high, health risks unclear The food and drinking water that people consume include chemicals that have effects on health. Among them are substances, such as lead, which are known to have a negative effect on intelligence or development of the brain.
GPs feel more personalised care for chronically ill patients was useful during coronavirus pandemic During the coronavirus pandemic, GPs had to take over some of the tasks of hospitals and mental healthcare providers.
Post-COVID less common after Omicron infection After a SARS-CoV-2 infection involving Omicron, 1 in 10 people still have symptoms three months later. This is almost 2 times lower than after an infection involving the Delta variant. This is evident from new results of the LongCOVID study at RIVM. There is variation in the frequency of specific post-COVID symptoms after an infection with the Omicron or Delta variant.
Number of tuberculosis patients in the Netherlands decreased slightly in 2022 compared to 2021 The number of people with tuberculosis (TB) in the Netherlands decreased slightly in 2022. In 2022, there were 635 TB patients in the Netherlands. This is six per cent fewer than in 2021, when there were 673 patients.
COVID-19 less severe due to Omicron variants, vaccinations and previous infections The consequences of infections involving the coronavirus SARS-CoV-2 are decreasing. This is because nearly everyone in the Netherlands has built up immunity to COVID-19 as a result of vaccination and/or previous infection, and because the current Omicron variants are less likely to cause serious illness.
Drop in and get vaccinated without an appointment on HPV Awareness Day Saturday 4 March is HPV Awareness Day. It is a day to stop and think about the human papillomavirus (HPV) and the six kinds of cancer it can cause. These cancers affect both men and women.